|
ALX Oncology Holdings Common
(ALXO)
|
16.2 |
$364M |
|
4.2M |
86.20 |
|
Ascendis Pharma A/S Sponsored Adr
(ASND)
|
13.4 |
$300M |
|
1.8M |
166.78 |
|
Harmony Biosciences Holdings Common
(HRMY)
|
7.3 |
$164M |
|
4.5M |
36.15 |
|
Tarsus Pharmaceuticals Common
(TARS)
|
6.0 |
$134M |
|
3.2M |
41.33 |
|
New Frontier Health Corp Ord Shs
|
5.5 |
$123M |
|
14M |
8.60 |
|
Aligos Therapeutics Common
|
4.4 |
$98M |
|
3.5M |
27.65 |
|
Genetron Holdings Ads
|
4.0 |
$89M |
|
6.3M |
14.00 |
|
Amyris Common
|
3.6 |
$81M |
|
13M |
6.17 |
|
Legend Biotech Corp Sponsored Sponsored Ads
(LEGN)
|
3.5 |
$78M |
|
2.8M |
28.16 |
|
Olema Pharmaceuticals Common
(OLMA)
|
2.7 |
$60M |
|
1.2M |
48.08 |
|
Iveric Bio Common
|
1.8 |
$41M |
|
6.0M |
6.91 |
|
Sinovac Biotech SHS
|
1.7 |
$38M |
|
5.9M |
6.47 |
|
Passage Bio Common
|
1.7 |
$38M |
|
1.5M |
25.57 |
|
Crinetics Pharmaceuticals Common
(CRNX)
|
1.5 |
$33M |
|
2.3M |
14.11 |
|
Nkarta Common
(NKTX)
|
1.4 |
$32M |
|
512k |
61.47 |
|
Sierra Oncology Common
|
1.4 |
$31M |
|
1.9M |
16.03 |
|
KalVista Pharmaceuticals Common
(KALV)
|
1.4 |
$31M |
|
1.6M |
18.99 |
|
Arcutis Biotherapeutics Common
(ARQT)
|
1.1 |
$24M |
|
867k |
28.13 |
|
Kadmon Holdings Common
|
1.1 |
$24M |
|
5.8M |
4.15 |
|
Zai Lab Adr
(ZLAB)
|
1.1 |
$24M |
|
175k |
135.34 |
|
Avadel Pharmaceuticals Adr
|
1.1 |
$24M |
|
3.5M |
6.68 |
|
Celldex Therapeutics Common
(CLDX)
|
1.0 |
$23M |
|
1.3M |
17.52 |
|
Essa Pharma Common
(EPIX)
|
1.0 |
$23M |
|
1.9M |
11.93 |
|
Eiger BioPharmaceuticals Common
|
1.0 |
$22M |
|
1.8M |
12.29 |
|
Verona Pharma Ads
(VRNA)
|
1.0 |
$21M |
|
3.0M |
7.00 |
|
Zogenix Common
|
0.9 |
$20M |
|
1.0M |
19.99 |
|
Chinook Therapeutics Common
|
0.9 |
$19M |
|
1.2M |
15.86 |
|
Novavax Common
(NVAX)
|
0.8 |
$18M |
|
158k |
111.51 |
|
Kura Oncology Common
(KURA)
|
0.8 |
$17M |
|
525k |
32.66 |
|
Larimar Therapeutics Common
(LRMR)
|
0.8 |
$17M |
|
800k |
21.41 |
|
Rocket Pharmaceuticals Common
(RCKT)
|
0.8 |
$17M |
|
311k |
54.84 |
|
Akero Therapeutics Common
(AKRO)
|
0.7 |
$16M |
|
633k |
25.80 |
|
Immunovant Common
(IMVT)
|
0.7 |
$16M |
|
348k |
46.19 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.7 |
$16M |
|
205k |
76.73 |
|
Mereo Biopharma Group Ads
(MREO)
|
0.7 |
$15M |
|
4.2M |
3.58 |
|
Cytokinetics Common
(CYTK)
|
0.6 |
$15M |
|
700k |
20.78 |
|
Zymeworks Common
|
0.6 |
$14M |
|
286k |
47.26 |
|
Curis Common
|
0.5 |
$12M |
|
1.4M |
8.19 |
|
Aclaris Therapeutics Common
(ACRS)
|
0.5 |
$11M |
|
1.6M |
6.47 |
|
Calliditas Therapeutics Sponsored Ads
|
0.5 |
$11M |
|
311k |
33.62 |
|
Poseida Therapeutics Common
(PSTX)
|
0.5 |
$10M |
|
926k |
10.97 |
|
Homology Medicines Common
|
0.4 |
$9.6M |
|
853k |
11.29 |
|
Matinas Biopharma Hldgs Common
|
0.4 |
$8.8M |
|
6.5M |
1.36 |
|
Codexis Common
(CDXS)
|
0.4 |
$8.5M |
|
388k |
21.83 |
|
10X Genomics CL A Common
(TXG)
|
0.4 |
$8.4M |
|
59k |
141.60 |
|
Aurinia Pharmaceuticals Common
(AUPH)
|
0.3 |
$6.9M |
|
501k |
13.83 |
|
Dyne Therapeutics Common
(DYN)
|
0.3 |
$6.6M |
|
315k |
21.00 |
|
Orchard Therapeutics Ads
|
0.3 |
$5.7M |
|
1.3M |
4.32 |
|
Kala Pharmaceuticals Common
|
0.2 |
$5.3M |
|
787k |
6.78 |
|
Constellation Pharmaceutical Common
|
0.2 |
$4.0M |
|
140k |
28.80 |
|
Atricure Common
(ATRC)
|
0.2 |
$3.6M |
|
65k |
55.67 |
|
Cymabay Therapeutics Common
|
0.1 |
$3.4M |
|
585k |
5.74 |
|
Ovid Therapeutics Common
(OVID)
|
0.1 |
$2.9M |
|
1.3M |
2.31 |
|
IGM Biosciences Common
(IGMS)
|
0.1 |
$1.8M |
|
20k |
88.30 |
|
VYNE Therapeutics Common
|
0.1 |
$1.5M |
|
940k |
1.58 |
|
Tricida Common
|
0.1 |
$1.2M |
|
175k |
7.05 |
|
Precision Biosciences Common
|
0.1 |
$1.2M |
|
140k |
8.34 |
|
Metacrine Common
|
0.1 |
$1.2M |
|
146k |
7.86 |
|
Revolution Medicines Common
(RVMD)
|
0.0 |
$661k |
|
17k |
39.60 |